|
|
|
Volumn 32, Issue 3, 2007, Pages 209-229
|
|
Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIOXIDANT;
CELL ADHESION MOLECULE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NEW DRUG;
POLYMER;
POLYOL;
PROTEIN KINASE C;
SIGNAL PEPTIDE;
BLOOD;
DIABETES MELLITUS;
DIABETIC ANGIOPATHY;
DIABETIC NEPHROPATHY;
DIET THERAPY;
DRUG ANTAGONISM;
HUMAN;
INFLAMMATION;
INSULIN RESISTANCE;
METABOLISM;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
THROMBOPHILIA;
VASCULAR ENDOTHELIUM;
VISUAL SYSTEM EXAMINATION;
ANTIHYPERTENSIVE AGENTS;
ANTIOXIDANTS;
CELL ADHESION MOLECULES;
DIABETES MELLITUS;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL;
DRUGS, INVESTIGATIONAL;
ENDOTHELIUM, VASCULAR;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPOGLYCEMIC AGENTS;
INFLAMMATION;
INSULIN RESISTANCE;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
OXIDATIVE STRESS;
POLYMERS;
PROTEIN KINASE C;
THROMBOPHILIA;
|
|
EID: 40349087464
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (29)
|
|
References (93)
|
